Klinische Studie

Neoadjuvant Radiochemotherapy versus Chemotherapy for Patients with Locally Advanced, Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ)(RACE)Neoadjuvant Radiochemotherapy versus Chemotherapy for Patients with Locally Advanced, Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction
EUDRACT2018-001728-20
NCT-
DRKS-
Krankheitsentität(en) Speiseröhre
StudientypInterventionsstudiePhase III
Wesentliche EinschlusskriterienHistologically proven, locally advaced and potentially resectable adenoCA of the gastroesophageal junction Patients must be candidates for potential curative resection as determined by the treating surgeon ECOG 0-1
Wesentliche AusschlusskriterienEvidence of metastatic disease Past or current history of other malignancies
Statusrekrutierend
Ansprechpartner & KontaktUniversitätsklinikum RegensburgInnere Medizin IStudienzentrale0941 9447063studienzentrum.innere1(at)ukr.de
zurück